Paramount Pictures is actively acquiring across literary adaptation, prestige drama, and fantasy, with 309 tracked signals in the past 12 months and a recent slate spanning horror thrillers, horror romance, franchise extensions, and a first-look deal with Jon M. Chu.
Each signal is one documented data point captured by our continuous pipeline: a trade-press mention, festival market activity, executive statement, or acquisition activity update. Higher signal volume means Paramount Pictures is generating more public market activity right now.
"2022 was the first year in nearly a decade where Paramount crossed $1 Billion at the domestic box office and ranked as a top three Studio."
Paramount Pictures is currently operating from a position of consolidated leadership under CEO Brian Robbins, following the departure of Andrew Gumpert and a restructuring that places strategic planning, labor relations, and studio operations under tighter executive oversight. The studio's recent landmark was crossing $1 billion at the domestic box office in 2022 for the first time in nearly a decade, a milestone cited internally as evidence of institutional momentum. Ongoing corporate integration, including the folding of Showtime into Paramount+, signals continued cost discipline alongside selective theatrical investment.
Over the past 12 months, Paramount has logged 309 tracked activity records, reflecting a broad and consistent acquisition posture. The studio's recent deals span pre-emptive script buys (the original horror thriller "Familiar" by Julien Magnat), franchise extensions ("Scary Movie 6," the live-action "Call of Duty" feature adaptation), genre sequels ("Heart Eyes 2," distributed through Paramount with a 2028 release date), and a first-look producing deal with Jon M. Chu. The pattern points to a studio balancing franchise infrastructure with targeted bets on original and adapted material, particularly in horror, thriller, and high-concept genres. Budget discipline is evident: "80 for Brady" was financed at $28M, and "Heart Eyes 2" is tracking under $25M.
Access to Paramount runs primarily through established representation channels and producer relationships. The studio's first-look deal with Jon M. Chu and its history of pre-emptive buys on spec scripts indicate that well-packaged material with clear commercial positioning, ideally with attached talent or a producing partner, moves fastest. With 238 decision makers tracked and deal velocity registering at 10 signals in the past 30 days, the studio remains an active buyer despite zero closed deals in the most recent 30-day window, suggesting a pipeline in active development rather than a pause in appetite.
"2022 was the first year in nearly a decade where Paramount crossed $1 Billion at the domestic box office and ranked as a top three Studio."
Studio demand surging for high-concept non-franchise literary IP with A-list talent, as franchise fatigue and streamer pullback from prestige budgets creates theatrical acquisition opportunities at Cannes.
This page is a public snapshot of Paramount Pictures, kept fresh from trade-press signals. ScriptMatch is the live market-data engine behind it. Upload your script, and we use the same continuously-indexed buyer activity to tell you which production companies and distributors are actively acquiring projects like yours right now, why each one fits, and exactly how to reach them.
Paramount does not have a publicized open-submission policy for unsolicited material. The studio's acquisition history, including its pre-emptive buy of the original spec script 'Familiar' by Julien Magnat, suggests that material reaches the studio through literary agents, entertainment attorneys, or established producer relationships. Writers without representation are strongly advised to secure agency or management before approaching Paramount through any channel.
Paramount's disclosed acquisition budgets skew toward the mid-range for non-franchise originals. '80 for Brady' was financed at $28M, and 'Heart Eyes 2' is reportedly tracking under $25M. The studio's broader budget range is noted at up to $70M for acquisitions, with larger franchise productions handled separately. Cost discipline has been a stated priority following corporate consolidation moves including the Showtime-into-Paramount+ integration.
Paramount operates in the broader market context where, according to recent industry analysis, studio demand is surging for high-concept non-franchise literary IP with A-list talent at events like Cannes, as franchise fatigue and streamer pullback from prestige budgets create theatrical acquisition opportunities. Paramount's active posture across 309 tracked signals in 12 months positions it as a participant in that market, though specific festival acquisitions in the current cycle are not confirmed in available records.
Paramount has 238 decision makers currently tracked across creative, strategic, and operational divisions. Following the departure of Andrew Gumpert, Courtney Armstrong assumed responsibility for Strategic Planning and Labor Relations, reporting to Brian Robbins, while Randall Baumberger oversees Studio Operations. The studio's first-look deal with Jon M. Chu illustrates that producer partnerships are a primary access pathway. Representation through a recognized literary or talent agency remains the most reliable route to the relevant creative executives.
Paramount's current content focus spans literary adaptation, prestige drama, and fantasy, per tracked mandate data. Recent acquisitions reflect a parallel appetite for horror thriller ('Familiar'), horror romance ('Heart Eyes 2'), franchise comedy extension ('Scary Movie 6'), and video game adaptation ('Call of Duty' live-action feature). The studio's global franchise portfolio, cited internally as including Mission: Impossible, Sonic the Hedgehog, Star Trek, and Transformers, continues to anchor the slate alongside these more targeted bets.
Yes. Paramount has logged 309 tracked activity records in the past 12 months and maintains a deal velocity of 10 signals in the most recent 30-day window, though zero deals closed in that same 30-day period, suggesting active pipeline development. The most recent confirmed acquisition signal dates to May 2026. The studio's first-look deal with Jon M. Chu (reported January 2026) and the greenlit 'Heart Eyes 2' (April 2026) confirm continued forward momentum across both original and sequel material.
Profile compiled from publicly-available sources: trade press (Deadline, Variety, IndieWire, The Hollywood Reporter, Screen Daily), festival market reports (Cannes Marche, AFM, EFM, TIFF Industry), executive public statements, and acquisition announcements. Activity counters reflect signal volume from continuous pipeline indexing.
See an inaccuracy? Suggest a correction. Profiles update continuously as new public information becomes available.